However, ALDH3A2 couldn’t effectively predict the prognosis for patients with STAD, and this inconsistent effects of ALDH3A2 on prognosis may be caused by the different inclusion and exclusion criteria across different study, which needs more comprehensive investigation. This evidence concerns the gene ALDH3A2 and gastric adenocarcinoma.